Appeals Court Affirms FDA on Denial of Prescription Generics for Bayer Laxative

A federal appeals court has backed up the FDA’s decision to block prescription generics of Bayer’s MiraLax after the branded version switched to over-the-counter status.
Source: Drug Industry Daily